drugset / Trial / NCT06329167

Daphnetin Capsules for Lower Limb Lymphoedema Following Gynaecological Surgery

NCT06329167 ↗

Phase 4 Unknown 100 enrolled The First Hospital of Jilin University
RandomizedParallel-groupOpen-labelTreatment

Summary

This clinical trial is designed to learn more about treating patients with lower limb lymphoedema following gynaecological surgery. The main question to be answered is To evaluate the efficacy of Daphnetin capsule in the treatment of patients with lower limb lymphedema following gynaecological malignancy surgery. Participants will take Daphnetin capsule 150mg tid (3 capsules/time, 3 times daily) orally at the same time as gradient compression stocking treatment. Researchers will compare 150mg Forte tablets (2 capsules/time, 2 times daily) and gradient compression stockings to see if Daphnetin capsule can be used to treat patients with lower extremity lymphedema following gynaecological malignancy surgery.

Timeline

Start
2024-03-25
Primary completion
2025-07-01
Completion
2025-07-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aescuven Unknown 150 mg Oral
Subject Daphnetin Small molecule 150 mg Oral

Indications